Cumberland Pharmaceuticals Inc. (CPIX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Specialty Pharmaceutical Products	44.52M	37.87M	39.55M	42.01M	35.99M
Specialty Pharmaceutical Products Growth	17.57%	-4.26%	-5.85%	16.75%	-3.89%
Total	44.52M	37.87M	39.55M	42.01M	35.99M
Total Growth	17.57%	-4.26%	-5.85%	16.75%	-3.89%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	39.62M	35.17M	38.45M	40.51M	33.79M
United States Growth	12.66%	-8.54%	-5.08%	19.91%	-3.58%
China	2.98M	-	-	-	-
South Korea	1.32M	1.49M	-	-	-
South Korea Growth	-11.00%	-	-	-	-
Russia	429.19K	465.54K	-	-	-
Russia Growth	-7.81%	-	-	-	-
Mexico	120.00K	8.68K	-	-	-
Mexico Growth	1282.01%	-	-	-	-
Australia	31.46K	54.00K	-	-	-
Australia Growth	-41.74%	-	-	-	-
Saudi Arabia	13.00K	650.00K	-	-	-
Saudi Arabia Growth	-98.00%	-	-	-	-
Other Outside The United States	9.28K	36.38K	-	-	-
Other Outside The United States Growth	-74.49%	-	-	-	-
Outside The United States	-	-	1.10M	1.50M	2.20M
Outside The United States Growth	-	-	-26.67%	-31.82%	-8.33%
Total	44.52M	37.87M	39.55M	42.01M	35.99M
Total Growth	17.57%	-4.26%	-5.85%	16.75%	-3.89%

Source: S&P Global Market Intelligence.